My vote would be to keep this thread regarding the fundamentals of AVZ and its relationship to the share price as opposed to a back patting/finger wagging fest.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%